Research in Neuroscience

Research in Neuroscience is a peer-reviewed journal aims to advance our understanding of the nervous system in health and disease, thereby improving the diagnosis and treatment of neuropsychiatric and neurodegenerative disorders. It presents novel results that can be of interest to a broad spectrum of neuroscientists and that were generated by experiments guided by clearly defined aims or hypotheses.

Catherine King

Editorial Board Member of Research in Neuroscience

Lecturer, University of South Australia, Australia

Research Areas

Genetics and Pharmacogenomics of Autoimmune Diseases, Primarily Multiple Sclerosis

Education

2007Doctor of PhilosophyQueen's University Belfast
2003MPharmQueen's University Belfast

Experience

2008-PresentLecturer in Life Sciences, UniSA

Publications: Journals

[1]  Main P., Angley M., Thomas P., O'Doherty C., and Fenech M. Folate and methionine metabolism and autism: a systematic review (2010). Am J Clin Nutr 91:1–26 (A*, IF 6.3)
[2]  O'Doherty C., Alloza I., Rooney M., Vandenbroeck K. IL7RA polymorphisms and chronic inflammatory arthropathies (2009). Tissue Antigens 74 (5): 429-431 (A , IF 2.2)
[3]  O'Doherty C., Favorov F., Heggarty S., Graham C., Favorova O., Ochs M., Hawkins S., Hutchinson M., O'Rourke K., Vandenbroeck K. Genetic polymorphisms, their allele combinations and IFN-a treatment response in Irish multiple sclerosis patients (2009) Pharmacogenomics. 10(7): 1177-1186 (B, IF 3.5)
[4]  O'Doherty C., Kantarci O.H., and Vandenbroeck K.: IL7RA polymorphisms and susceptibility to multiple sclerosis (2008) The New England Journal of Medicine 358:753-754). (A*, IF 52.6)
[5]  O'Doherty C., Roos I., Antigüedad A., Aransay A.M., Hillert J. and Vandenbroeck K.: ITGA4 polymorphisms and susceptibility to multiple sclerosis (2007). Journal of Neuroimmunology 189:151-157 (B, IF 2.9)
[6]  O'Doherty C., Hawkins S.A., Rooney M. and Vandenbroeck K.: The MHC2TA-168 A/G and +1614 G/C polymorphisms and risk for multiple sclerosis or chronic inflammatory arthropathies. (2007). Tissue Antigens. 70:247-251 (A , IF 2.2)
[7]  O'Doherty, C., Villoslada, P., Vandenbroeck, K. 2007. Pharmacogenomics of type I interferon therapy: a survey of response modifying genes. Cytokine & Growth Factor Reviews (2007). 18:211-222. (A, IF 11.8)
[8]  Heggarty S., Suppiah V., Silversides J., O'Doherty C., Droogan A., McDonnell G., Hawkins S., Graham C., and Vandenbroeck K.. CTLA4 gene polymorphisms and multiple sclerosis in Northern Ireland (2007) Journal of Neuroimmunology. 187:187-191(B, IF 2.9)
[9]  Cunningham S., O'Doherty C., Patterson C., McDonnell G., Hawkins S., Marrosu M.G., and Vandenbroeck K. :The neuropeptide genes TAC1, TAC3, TAC4, VIP and PACAP (ADCYAP1), and susceptibility to multiple sclerosis (2007). Journal of Neuroimmunology 183:208-213 (B, IF 2.9)
[10]  Suppiah V., O'Doherty C., Heggarty S., Patterson C., Rooney M., Vandenbroeck K. The CTLA4+49A/G and CT60 polymorphisms and chronic inflammatory arthropathies in Northern Ireland. (2006) Experimental & Molecular Pathology. 80(2):141-6. (C, IF 1.8)